138 related articles for article (PubMed ID: 6177400)
1. Flow cytofluorometric detection of tumor-specific rosette-forming cells in patients with squamous cell carcinoma of the head and neck.
Tong AW; Vanderbark AA; Kraybill W; Vetto RM; Burger DR
Cancer Res; 1982 Jul; 42(7):2949-55. PubMed ID: 6177400
[TBL] [Abstract][Full Text] [Related]
2. Immunological status of patients in carcinoma head and neck.
Vasenwala SM; Aziz M; Rattan A; Ahmad KN
Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
[TBL] [Abstract][Full Text] [Related]
3. A search for common tumor specific antigen and serum blocking factor in head and neck epidermoid carcinomas.
Kennedy JT
Laryngoscope; 1975 May; 85(5):806-22. PubMed ID: 49834
[TBL] [Abstract][Full Text] [Related]
4. Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.
Dawson DE; Everts EC; Vetto RM; Burger DR
Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):342-5. PubMed ID: 3875306
[TBL] [Abstract][Full Text] [Related]
5. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
[TBL] [Abstract][Full Text] [Related]
6. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the mechanism of the leukocyte adherence inhibition test.
Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
[TBL] [Abstract][Full Text] [Related]
8. High-affinity erythrocyte rosette formation and inhibition in premalignant disease of the uterine cervix.
Bashford J; Gough IR
Cancer Res; 1983 Aug; 43(8):3955-8. PubMed ID: 6861158
[TBL] [Abstract][Full Text] [Related]
9. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
Kienstra MA; Neel HB; Strome SE; Roche P
Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237
[TBL] [Abstract][Full Text] [Related]
10. Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma.
Kato H; Whiteside TL
Tokai J Exp Clin Med; 2011 Dec; 36(4):144-51. PubMed ID: 22167499
[TBL] [Abstract][Full Text] [Related]
11. Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis.
Kross KW; Heimdal JH; Olsnes C; Olofsson J; Aarstad HJ
Scand J Immunol; 2008 Apr; 67(4):392-9. PubMed ID: 18282234
[TBL] [Abstract][Full Text] [Related]
12. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
[No Abstract] [Full Text] [Related]
13. Serum blocking factors in bovine ocular squamous cell carcinoma demonstrated by inhibition of erythrocyte rosette augmentation.
Kuchroo VK; Halliday WJ; Jennings PA; Spradbrow PB
Cancer Res; 1983 Mar; 43(3):1325-9. PubMed ID: 6600651
[TBL] [Abstract][Full Text] [Related]
14. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated antigens in cervical cancer tissues and in sera from patients with cervical cancer or with head and neck cancer.
Ibrahim AN; Robinson RA; Marr L; Abdelal AT; Nahmias AJ
J Natl Cancer Inst; 1979 Aug; 63(2):319-23. PubMed ID: 88537
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer.
Saito T; Kuss I; Dworacki G; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 1999 Jun; 5(6):1263-73. PubMed ID: 10389908
[TBL] [Abstract][Full Text] [Related]
18. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of MUC1 and carbohydrate antigens in primary and secondary head and neck squamous cell carcinoma.
Croce MV; Rabassa ME; Pereyra A; Segal-Eiras A
Head Neck; 2008 May; 30(5):647-57. PubMed ID: 18302268
[TBL] [Abstract][Full Text] [Related]
20. Antigenic epitopes of three tumor-associated antigens of well-differentiated squamous cell carcinoma of the larynx for use in monitoring patients in specific active immunochemotherapy trials.
Hollinshead AC
Cancer Detect Prev; 1987; 10(3-4):153-8. PubMed ID: 2436778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
